Neurodegeneration and Neuroprotection in Parkinson’s Disease
Prof. Dr. Donato Di Monte
Group Leader
Venusberg-Campus 1, Gebäude 99
(ehemals Sigmund-Freud-Str. 27)
53127 Bonn
donato.dimonte@dzne.de
(ehemals Sigmund-Freud-Str. 27)
53127 Bonn
donato.dimonte@dzne.de
+49 228 43302-650
| Degrees | |
|---|---|
| 1983-1987 | Post-doctoral training, Karolinska Institute (Stockholm, Sweden) and University of California, Berkeley (USA) |
| 1981-1986 | Specialization (Internal Medicine), University of Bari (Italy) |
| 1975-1981 | Medical Degree, University of Bari (Italy) |
| Major previous appointments | |
|---|---|
| 2009-2012 | Senior Research Physician, Stanford Research Institute, Menlo Park (USA) |
| 1992-2009 | Lecturer, School of Public Health, University of California, Berkeley (USA) |
| 1990-2009 | Industry Consultant (e.g., Mylan, Otsuka, Elan, SunBio, Neuraltus) |
| 1989-2009 | Director of Fundamental Research, Parkinson’s Institute, Sunnyvale (USA) |
| Activities in the Scientific Community / Professional Memberships | |
|---|---|
| 2002-2007 | Chair of Steering Committee, Collaborative Centers for Parkinson’s Disease Environmental Research, NIEHS (USA) |
| 2000-2005 | National Institute of Neurological Disorders and Stroke (NINDS) Training Grant and Career Development Review Committee (USA) |
| 2002-2005 | Scientific Advisory Board of the Stanford Neuroscience Institute (USA) |
| Honors and Awards | |
|---|---|
| 2010 | United States Patent Number 7,718,677 “Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments” |
| since 1990 | Awardee of research grants (e.g. NIH, MJFox Foundation, CoEN, JPND) |